Cargando…

Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer

The endothelial lipase LIPG possesses serine phospholipase activity and is involved in lipoprotein metabolism. Our previous studies have revealed that LIPG overexpression is required for tumor formation and metastasis of human basal-like triple-negative breast cancer (TNBC). We also demonstrated tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo, Pang-Kuo, Yao, Yuan, Zhou, Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265491/ https://www.ncbi.nlm.nih.gov/pubmed/32488004 http://dx.doi.org/10.1038/s41598-020-65400-7

Ejemplares similares

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

LipG a bifunctional phospholipase/thioesterase involved in mycobacterial envelope remodeling
por: Santucci, Pierre, et al.
Publicado: (2018)

LIPG endothelial lipase and breast cancer risk by subtypes
por: Gago-Dominguez, Manuela, et al.
Publicado: (2021)

LIPG supports adaption to oxidative stress
por: Leonhardt, Gregor
Publicado: (2019)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Cancer stem cells and early stage basal-like breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2016)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

LIPG‐promoted lipid storage mediates adaptation to oxidative stress in breast cancer
por: Cadenas, Cristina, et al.
Publicado: (2019)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

p16 expression correlates with basal-like triple-negative breast carcinoma
por: Abou-Bakr, Amany A, et al.
Publicado: (2013)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
por: Slebe, Felipe, et al.
Publicado: (2016)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer
por: Yao, Qian, et al.
Publicado: (2022)

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
por: Storr, S. J., et al.
Publicado: (2012)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels
por: Yang, Shuo, et al.
Publicado: (2019)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013)

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
por: Zhao, Hua, et al.
Publicado: (2015)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
por: Soyama, Hirotoshi, et al.
Publicado: (2022)

Association between the LIPG polymorphisms and serum lipid levels in the Maonan and Han populations
por: Yang, Shuo, et al.
Publicado: (2019)

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma
por: Wang, Shan, et al.
Publicado: (2022)

The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer
por: Li, Ziyao, et al.
Publicado: (2015)

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer
por: Zeng, Zeng, et al.
Publicado: (2017)

TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression
por: Bi, Jing, et al.
Publicado: (2023)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels
por: Razzaghi, Hamid, et al.
Publicado: (2012)

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
por: Olsson, Maxim, et al.
Publicado: (2023)

Mining the LIPG Allelic Spectrum Reveals the Contribution of Rare and Common Regulatory Variants to HDL Cholesterol
por: Khetarpal, Sumeet A., et al.
Publicado: (2011)

Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol
por: Tietjen, Ian, et al.
Publicado: (2012)

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes
por: Uva, Paolo, et al.
Publicado: (2018)

Osthole inhibits triple negative breast cancer cells by suppressing STAT3
por: Dai, Xuanxuan, et al.
Publicado: (2018)

Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
por: Li, Ying-Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i70pboivfj7839thf777jrudp9